Creating a New Class of Curative Medicines
 

creating a new class

of curative medicines

 
 
Artboard 15.jpg
 

Bastion Biologics develops high-valency therapeutics for blood cancers and solid tumors.

Our approach uses polymer-antibody conjugates to eliminate targeted cancers.